As we only focused on AR activity and the regulation of its downstream genes, it might be interesting to study the effect of LSD1 inhibitors on the activity of other transcription factors, and co-treatment with their inhibitors in kidney cancer. This evidence concerns the gene KDM1A and kidney cancer.